Home Newsfeeds JMP Securities Reiterates Market Outperform on Varonis Systems, Maintains $63 Price Target

JMP Securities Reiterates Market Outperform on Varonis Systems, Maintains $63 Price Target

JMP Securities analyst Erik Suppiger reiterates Varonis Systems (NASDAQ:VRNS) with a Market Outperform and maintains $63 price target.

byBenzinga Newsdesk

March 15, 2023

1 minute read

JMP Securities analyst Erik Suppiger reiterates Varonis Systems (NASDAQ:VRNS) with a Market Outperform and maintains $63 price target.

After Dropping Humana Acquisition Attempt Cigna In Talks To Sell Medicare Advantage Business Amid Competition

By Vandana Singh

December 15, 3:35 PM

Health Care Service Corporation (HCSC) and Elevance Health Inc (NYSE: ELV) are reportedly engaged in a competitive race to acquire the Medicare Advantage business segment from Cigna Group (NYSE:

What’s Going On With DraftKings Shares Monday?

By Vaishali Prayag

June 17, 4:23 PM

Shares of DraftKings Inc. (NASDAQ: DKNG) saw a significant uptick Monday afternoon. This surge comes on the heels of a pivotal decision by the U.S. Supreme Court that has significant implications for the future of online sports betting in Florida and optimism that taxes will not be introduced into New Jersey's 2025 budget which closes on June 30th.

DKNG

IceCure’s Medical’s Study Using ProSense Finds “Cryoablation Allows The Ultimate De-Escalation Of Surgical Therapy For Select Breast Cancer Patients”

By Benzinga Newsdesk

December 13, 9:10 AM

Independent study published in Annals of Surgical Oncology concludes cryoablation is an oncologically safe and feasible minimally invasive procedure option in lieu of surgery for patients with early-stage, low-risk

ICCM

NanoVibronix Cites Results From Independent Testing Of UroShield

By Happy Mohamed

August 30, 8:34 AM

University of Southampton Study Reports Positive Outcomes in Lab and Patient Testing NanoVibronix, Inc. (NASDAQ:NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield®

NAOV

JMP Securities Reiterates Market Outperform on Varonis Systems, Maintains $63 Price Target

Related Posts

After Dropping Humana Acquisition Attempt Cigna In Talks To Sell Medicare Advantage Business Amid Competition

What’s Going On With DraftKings Shares Monday?

IceCure’s Medical’s Study Using ProSense Finds “Cryoablation Allows The Ultimate De-Escalation Of Surgical Therapy For Select Breast Cancer Patients”

NanoVibronix Cites Results From Independent Testing Of UroShield